发明名称 KONDENSIERTE IMIDAZOLE ZUR KREBSBEHANDLUNG
摘要 Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.
申请公布号 DE602008005894(D1) 申请公布日期 2011.05.12
申请号 DE20086005894T 申请日期 2008.08.14
申请人 BAYER SCHERING PHARMA AKTIENGESELLSCHAFT 发明人 HOELDER, SWEN;ZUELCH, ARMIN;BAER, THOMAS;MAIER, THOMAS;ZIMMERMANN, ASTRID;BECKERS, THOMAS;GEKELER, VOLKER;JOSHI, HEMANT;MUNOT, YOGESH S.;BHISE, UMESH;CHAVAN, SUNIL;SHIVATARE, SACHIN S.;PATEL, SARVESH A.;GORE, VIKAS
分类号 C07D471/04;A61K31/437;A61K31/505;A61K31/53;A61P35/00;C07D487/04;C07D498/04;C07D513/04 主分类号 C07D471/04
代理机构 代理人
主权项
地址